DETECTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN HUMAN ATHEROSCLEROTIC LESIONS BY AN ANTI-MONOCYTE CHEMOATTRACTANT PROTEIN-1 MONOCLONAL-ANTIBODY

被引:253
|
作者
TAKEYA, M [1 ]
YOSHIMURA, T [1 ]
LEONARD, EJ [1 ]
TAKAHASHI, K [1 ]
机构
[1] NCI,FCRDC,IMMUNOBIOL LAB,IMMUNOPATHOL SECT,FREDERICK,MD 21701
关键词
MONOCYTE CHEMOATTRACTANT PROTEIN-1; ATHEROSCLEROSIS; ANTI-MONOCYTE CHEMOATTRACTANT PROTEIN-1; MONOCLONAL ANTIBODY; DOUBLE IMMUNOHISTOCHEMICAL STAINING;
D O I
10.1016/0046-8177(93)90166-E
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The infiltration of blood monocytes into the subendothelial space is thought to be one of the most important pathologic events in early atherogenesis. To examine the mechanism of monocyte migration in early atherosclerotic lesions we investigated immunohistochemically the production of monocyte chemoattractant protein-1 (MCP-1) in various atherosclerotic lesions, including diffuse intimal thickening, fatty streaks, and atheromatous plaques, obtained during autopsies of patients of various ages. A highly specific anti-MCP-1 monoclonal antibody that does not cross-react with neutrophil-activating, attractant protein-1/interleukin-8 or platelet proteins that have an amino acid sequence similar to MCP-1 was used to localize MCP-1 in situ. To characterize the cells constituting the atherosclerotic lesions a panel of monoclonal and polyclonal antibodies that are specific to smooth muscle cells (HHF-35), monocyte/macrophages (HAM56, Leu-M3, Leu-M5, EBM11, and PM-2K), and endothelial cells (anti-von Willebrand factor) was used. Double immunohistochemical staining with anti-MCP-1 and one of the cell type-specific antibodies was performed to identify the nature of MCP-1-positive cells. Endothelial cells stained positively for MCP-1 in nine of 14 diffuse intimal thickening lesions. Scattered macrophages in thickened intima also were positive for MCP-1. Endothelial staining of MCP-1 was observed in 14 of 21 fatty streak lesions. Subendothelial macrophages were strongly stained for MCP-1 in all fatty streak lesions examined. Subendothelial macrophages were stained for MCP-1 in atherosclerotic plaques; however, endothelial cells were only slightly positive for MCP-1. A few smooth muscle cells in the intima were positive for MCP-1 in atheromatous plaques. From these results it is concluded that the cell populations positive for MCP-1 are different in early and advanced atherosclerotic lesions, and that the endothelial cells and subendothelial macrophages are considered to be the major sources of MCP-1 in early atherosclerotic lesions. © 1993.
引用
收藏
页码:534 / 539
页数:6
相关论文
共 50 条
  • [1] Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 α in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy
    Göser, S
    Öttl, R
    Brodner, A
    Dengler, TJ
    Torzewski, J
    Egashira, K
    Rose, NR
    Katus, HA
    Kaya, Z
    CIRCULATION, 2005, 112 (22) : 3400 - 3407
  • [2] Anti-monocyte chemoattractant protein-1 gene therapy in collagen antibody-induced arthritis
    Belvoncikova, P.
    Borbelyova, V.
    Gromova, B.
    Schuh, B.
    Gardlik, R.
    Celec, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A166 - A166
  • [3] Monocyte chemoattractant protein-1 and the kidney
    Haller, Hermann
    Bertram, Anna
    Nadrowitz, Felix
    Menne, Jan
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2016, 25 (01): : 42 - 49
  • [4] Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions.
    Ohtsuki, K
    Hayase, M
    Akashi, K
    Kopiwoda, S
    Strauss, HW
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 180P - 180P
  • [5] MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN HUMAN ATHEROMATOUS PLAQUES
    NELKEN, NA
    COUGHLIN, SR
    GORDON, D
    WILCOX, JN
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (04): : 1121 - 1127
  • [6] MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN HUMAN ATHEROMATOUS PLAQUES
    NELKEN, NA
    COUGHLIN, SR
    GORDON, D
    WILCOX, JN
    CLINICAL RESEARCH, 1991, 39 (02): : A335 - A335
  • [7] MONOCYTE CHEMOATTRACTANT PROTEIN-3, BUT NOT MONOCYTE CHEMOATTRACTANT PROTEIN-2, IS A FUNCTIONAL LIGAND OF THE HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTOR
    FRANCI, C
    WONG, LM
    VANDAMME, J
    PROOST, P
    CHARO, IF
    JOURNAL OF IMMUNOLOGY, 1995, 154 (12): : 6511 - 6517
  • [8] Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
    Ikeda, Y
    Yonemitsu, Y
    Kataoka, C
    Kitamoto, S
    Yamaoka, T
    Nishida, KI
    Takeshita, A
    Egashira, K
    Sueishi, K
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (05): : H2021 - H2028
  • [9] Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice
    Inoshima, I
    Kuwano, K
    Hamada, N
    Hagimoto, N
    Yoshimi, M
    Maeyama, T
    Takeshita, A
    Kitamoto, S
    Egashira, K
    Hara, N
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (05) : L1038 - L1044
  • [10] HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1)
    LEONARD, EJ
    YOSHIMURA, T
    IMMUNOLOGY TODAY, 1990, 11 (03): : 97 - 101